Unknown

Dataset Information

0

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia.


ABSTRACT:

Background and objectives

Cells of innate immunity normally recover in the first weeks to months after allogenenic hematopoietic stem cell transplantation (allo-HSCT). Their relevance in terms of graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effect is largely unknown. The predictive role of early recovery in the immune cells on acute GVHD and GVL effect after allo-HSCT was investigated in patients with acute leukemia who achieved the first complete remission.

Methods

Peripheral blood samples were taken at the median of 14 days (range, 12∼29 days) after allo-HSCT. A cohort including 119 samples and characteristics of patients were analyzed. Immune cell populations were identified by flow cytometry.

Results

The median age was 49.0 years (range, 21∼69) at transplantation. Univariate analysis showed that age less than 40 years old, lower frequencies of CD8+ T cells, invariant natural killer T (iNKT) cells, monocytic myeloid derived suppressor cells (M-MDSCs) and higher frequency of immature MDSCs were associated with occurrence of grade III-IV acute GVHD. Multivariate analyses showed that iNKT cells (hazard ratio (HR), 0.453, 95% CI, 0.091∼0.844, p=0.024) and M-MDSCs (HR, 0.271, 95% CI, 0.078∼0.937, p=0.039) were independent factors. Combination of higher frequencies of both cell subsets was associated with lower incidence of grade III-IV acute GVHD, whereas patients with lower frequency of iNKT cells and higher frequency of M-MDSCs showed significant higher probability of relapse.

Conclusions

iNKT cells and M-MDSCs could be relevant cell biomarkers for predicting acute GVHD and/or relapse in acute leukemia patients treated with allo-HSCT.

SUBMITTER: Kim TW 

PROVIDER: S-EPMC6457701 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Predictive Role of Circulating Immune Cell Subtypes Early after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia.

Kim Tae Woo TW   Park Sung-Soo SS   Lim Ji-Young JY   Min Gi June GJ   Park Silvia S   Jeon Young-Woo YW   Yahng Seung-Ah SA   Shin Seung-Hwan SH   Lee Sung-Eun SE   Yoon Jae-Ho JH   Cho Byung-Sik BS   Eom Ki-Seong KS   Lee Seok S   Kim Hee-Je HJ   Min Chang-Ki CK  

International journal of stem cells 20181201 1


<h4>Background and objectives</h4>Cells of innate immunity normally recover in the first weeks to months after allogenenic hematopoietic stem cell transplantation (allo-HSCT). Their relevance in terms of graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effect is largely unknown. The predictive role of early recovery in the immune cells on acute GVHD and GVL effect after allo-HSCT was investigated in patients with acute leukemia who achieved the first complete remission.<h4>Method  ...[more]

Similar Datasets

| S-EPMC10200363 | biostudies-literature
| S-EPMC8432223 | biostudies-literature
| S-EPMC10232425 | biostudies-literature
| S-EPMC6865355 | biostudies-literature
| S-EPMC8478160 | biostudies-literature
| S-EPMC7786934 | biostudies-literature
| S-EPMC10471937 | biostudies-literature
| S-EPMC4471051 | biostudies-literature
| S-EPMC3951398 | biostudies-literature
| S-EPMC9689715 | biostudies-literature